semaglutide covered by tricare Q&A: For Life Coverage of Weight Loss Medications > TRICARE Newsroom > TRICARE News TRICARE Coverage of Weight Loss
Description
Data availability Transcriptomic analysis of sorted human beta cells are from Gene Expression Omnibus database, accession no
Semaglutide is a GLP-1 receptor agonist that is used to treat diabetes and obesity
I used to walk around 12,000 steps a day, go to the gym regularly, and play tennis
Italy: 73% cohort 1, 87% cohort 2)
Unlike Rybelsus, which was the first oral GLP-1 medication but still a peptide, orforglipron is the first non-peptide oral GLP-1 receptor agonist
